India Pharmaceutical Packaging Market by Product (Specialty Bags, Parenteral Container and Others), and Material (Glass, Aluminum Foils, Plastics and Polymers, Paper and Paperboards and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030
The India pharmaceutical packaging market was valued at $1434.1 million in 2020, and is projected to reach $3027.14 million by 2030 at a CAGR of 7.54% from 2021 to 2030.
Packaging is the science, art, and technology of enclosing and protecting pharmaceutical products for distribution, storage, sale, and its use. It is the process of designing and providing presentation to the pharmaceutical product. It also offers protection, identification, convenience, compliance, and stability to the product. Packaging should be convenient to open and handle to customers. Attractive packaging is used for promotion and attracting the attention of the people for increase in sale. Packaging avoids the counterfeiting of the products.
India is the second most populated country across globe and rise in the geriatric population in the country creates demand for more convenient packaging for patient compliance and ease to use. Pharmaceutical packaging is used, and should be economical, to protect against biological, physical and chemical hazards. The efficient packing of pharmaceuticals essentially prevents contamination and provides drug safety, and convenience of delivery, and handling. Pharmaceutical packaging is thus, required to balance several complex considerations. However, rising packaging costs owing to stringent regulations and anti-counterfeiting efforts is likely to restrain the market growth. Thus, curbing these escalating packaging costs is one of the challenges faced by pharmaceutical packaging manufacturers.
Further, Plastics & polymers such as polyvinyl chloride, polypropylene, polyethylene terephthalate, and polystyrene among others are widely used for manufacturing various pharmaceutical packaging products. Polypropylene material is anticipated to have the highest growth rate over the forecast period. Polypropylene is considered as an economical material and is being widely employed in the packaging industry.
Packaging also provides brand protection to prevent counterfeiting is also a significant factor that enhances competition in the market. The development of new packaging technologies such as child-resistant packaging (CRP), radiofrequency identification technology, and others with improved properties have led to the rapid growth of the market. The adoption and compliance with regulatory norms in pharmaceutical packaging, along with standards about packaging recycling fuels the growth of the market.
The India pharmaceutical packaging market is segmented into product and material. On the basis of product type, the market is divided into specialty bags, parenteral container and others. The specialty bags are further segmented urinary collection bags, bile collection bags, blood bags, sterile packaging bags, and enteral feeding. Further, parenteral container is split into bags, bottles, ampoules, vials, cartridges and others. The material type segment is further divided into glass, aluminum foils, plastics and polymers, paper and paperboards and others. The report provides an extensive competitive analysis and profiles of the key market players such as Amcor Plc., West Pharmaceutical Packaging India Pvt. Ltd., SGD Pharma India Ltd, Aptar Group, Inc., Uflex Limited, Essel Propack Ltd, Huhtamaki Ppl Ltd, Parekhplast India Limited, Nipro Corporation, Schott Pharmaceutical Packaging.
KEY BENEFITS FOR STAKEHOLDERS
Packaging is the science, art, and technology of enclosing and protecting pharmaceutical products for distribution, storage, sale, and its use. It is the process of designing and providing presentation to the pharmaceutical product. It also offers protection, identification, convenience, compliance, and stability to the product. Packaging should be convenient to open and handle to customers. Attractive packaging is used for promotion and attracting the attention of the people for increase in sale. Packaging avoids the counterfeiting of the products.
India is the second most populated country across globe and rise in the geriatric population in the country creates demand for more convenient packaging for patient compliance and ease to use. Pharmaceutical packaging is used, and should be economical, to protect against biological, physical and chemical hazards. The efficient packing of pharmaceuticals essentially prevents contamination and provides drug safety, and convenience of delivery, and handling. Pharmaceutical packaging is thus, required to balance several complex considerations. However, rising packaging costs owing to stringent regulations and anti-counterfeiting efforts is likely to restrain the market growth. Thus, curbing these escalating packaging costs is one of the challenges faced by pharmaceutical packaging manufacturers.
Further, Plastics & polymers such as polyvinyl chloride, polypropylene, polyethylene terephthalate, and polystyrene among others are widely used for manufacturing various pharmaceutical packaging products. Polypropylene material is anticipated to have the highest growth rate over the forecast period. Polypropylene is considered as an economical material and is being widely employed in the packaging industry.
Packaging also provides brand protection to prevent counterfeiting is also a significant factor that enhances competition in the market. The development of new packaging technologies such as child-resistant packaging (CRP), radiofrequency identification technology, and others with improved properties have led to the rapid growth of the market. The adoption and compliance with regulatory norms in pharmaceutical packaging, along with standards about packaging recycling fuels the growth of the market.
The India pharmaceutical packaging market is segmented into product and material. On the basis of product type, the market is divided into specialty bags, parenteral container and others. The specialty bags are further segmented urinary collection bags, bile collection bags, blood bags, sterile packaging bags, and enteral feeding. Further, parenteral container is split into bags, bottles, ampoules, vials, cartridges and others. The material type segment is further divided into glass, aluminum foils, plastics and polymers, paper and paperboards and others. The report provides an extensive competitive analysis and profiles of the key market players such as Amcor Plc., West Pharmaceutical Packaging India Pvt. Ltd., SGD Pharma India Ltd, Aptar Group, Inc., Uflex Limited, Essel Propack Ltd, Huhtamaki Ppl Ltd, Parekhplast India Limited, Nipro Corporation, Schott Pharmaceutical Packaging.
KEY BENEFITS FOR STAKEHOLDERS
- The study presents an in-depth analysis of the India pharmaceutical packaging market along with the current trends and future estimations from 2021 to 2030 to elucidate the imminent investment pockets.
- A comprehensive analysis of the factors that drive and restrict the market growth is provided.
- Identification of factors instrumental in changing the market scenario, rise in opportunities, and recognition of the key players that can influence this market on a global & regional scale are provided in the report.
- Key players are profiled, and their strategies are analyzed thoroughly to understand the competitive outlook of the market.
- By Product
- Bottles
- Specialty bags
- Urinary collection bags
- Bile collection bags
- Blood bags
- Sterile packaging bags
- Enteral feeding
- Parenteral container
- Bags
- Bottles
- Ampoules
- Vials
- Cartridges
- Others
- Others
- By Material Type
- Glass
- Aluminum foils
- Plastics and polymers
- Paper and paperboards
- Others.
- AdvaCare Pharma
- Amcor Plc.
- West Pharmaceutical Packaging India Pvt. Ltd.
- SGD Pharma India Ltd
- Aptar Group, Inc.
- Uflex Limited
- Essel Propack Ltd
- Huhtamaki PPL Ltd
- Parekhplast India Limited
- Nipro Corporation
- Schott Pharmaceutical Packaging
CHAPTER 1: INTRODUCTION
1.1. Report description
1.1.1. Key benefits for stakeholders
1.1.2. Key market segments
1.1.3. List of key players profiled in the report
1.2. Research methodology
1.2.1. Secondary research
1.2.2. Primary research
1.2.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Top player positioning, 2020
3.4. Porter’s five forces analysis
3.5. Impact analysis of COVID-19 on the pharmaceutical packaging market
3.6. Market dynamics
3.6.1. Drivers
3.6.1.1. Advanced manufacturing processes to develop sustainable and eco-friendly packaging solutions
3.6.1.2. Increase in product innovations and merger & acquisition to support new demands
3.6.1.3. Emerging generic drug market and rapidly growing drug delivery market
3.6.1.4. Increase in R&D and use of innovative packaging
3.6.2. Restraints
3.6.2.1. Price volatility of raw materials
3.6.2.2. Stringent government regulations and standards
3.6.3. Opportunities
3.6.3.1. Advancement in the biotechnology sector results in the introduction of new parenteral therapies and demand for innovative packaging products
3.6.3.2. Growth in use of the smart packaging for patient engagement and identification
3.6.3.3. Increase in a patient-oriented medicines including biologics
3.6.4. Impact analysis
CHAPTER 4: PHARMACEUTICAL PACKAGING MARKET, BY PRODUCT TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Specialty Bags
4.2.1. Key growth factors and opportunities
4.2.2. Product Type, By Specialty Bags
4.2.2.1. Market size and forecast
4.2.2.2. Urinary Collection Bags
4.2.2.2.1. Market size and forecast
4.2.2.3. Bile Collection Bags
4.2.2.3.1. Market size and forecast
4.2.2.4. Blood Bags
4.2.2.4.1. Market size and forecast
4.2.2.5. Sterile Packaging Bags
4.2.2.5.1. Market size and forecast
4.2.2.6. Enteral Feeding
4.2.2.6.1. Market size and forecast
4.3. Parenteral container
4.3.1. Key market trends and opportunities
4.3.2. Product Type, By Parenteral Container
4.3.2.1. Market size and forecast
4.3.2.2. Bags
4.3.2.2.1. Market size and forecast
4.3.2.3. Bottles
4.3.2.3.1. Market size and forecast
4.3.2.4. Ampoules
4.3.2.4.1. Market size and forecast
4.3.2.5. Vials
4.3.2.5.1. Market size and forecast
4.3.2.6. Cartridges
4.3.2.6.1. Market size and forecast
4.3.2.7. Others
4.3.2.7.1. Market size and forecast
4.4. Others
4.4.1. Key market trends and opportunities
CHAPTER 5: PHARMACEUTICAL PACKAGING MARKET, BY MATERIAL
5.1. Overview
5.1.1. Market size and forecast
5.2. Glass
5.2.1. Key growth factors and opportunities
5.2.2. Market size and forecast
5.3. Aluminum foils
5.3.1. Key growth factors and opportunities
5.3.2. Market size and forecast
5.4. Plastics and polymers
5.4.1. Key growth factors and opportunities
5.4.2. Market size and forecast
5.5. Paper & paperboards
5.5.1. Key growth factors and opportunities
5.5.2. Market size and forecast
5.6. Others
5.6.1. Key growth factors and opportunities
5.6.2. Market size and forecast
CHAPTER 6: COMPANY PROFILES
6.1. Amcor Plc.
6.1.1. Company overview
6.1.2. Company snapshot
6.1.3. Operating business segments
6.1.4. Product portfolio
6.1.5. Business performance
6.1.6. Key strategic moves and developments
6.2. Aptar Group Inc.
6.2.1. Company overview
6.2.2. Company snapshot
6.2.3. Operating business segments
6.2.4. Product Portfolio
6.2.5. Business performance
6.2.6. Key strategic moves and developments
6.3. ESSEL PROPACK LIMITED.
6.3.1. Company overview
6.3.2. Company snapshot
6.3.3. Operating business segments
6.3.4. Product Portfolio
6.3.5. Business performance
6.3.6. Key strategic moves and developments
6.4. Huhtamaki plc.
6.4.1. Company overview
6.4.2. Company snapshot
6.4.3. Operating business segments
6.4.4. Product Portfolio
6.4.5. Business performance
6.4.6. Key strategic moves and developments
6.5. Nipro Corporation
6.5.1. Company overview
6.5.2. Company snapshot
6.5.3. Operating business segments
6.5.4. Product portfolio
6.5.5. Business performance
6.6. Parekhplast plc.
6.6.1. Company overview
6.6.2. Company snapshot
6.6.3. Operating business segments
6.6.4. Product portfolio
6.7. SCHOTT AG
6.7.1. Company overview
6.7.2. Company snapshot
6.7.3. Operating business segments
6.7.4. Product portfolio
6.7.5. Business performance
6.8. SGD PHARMA INDIA LIMITED.
6.8.1. Company overview
6.8.2. Company snapshot
6.8.3. Operating business segments
6.8.4. Product portfolio
6.8.5. Business performance
6.9. UFLEX LIMITED
6.9.1. Company overview
6.9.2. Company snapshot
6.9.3. Operating business segments
6.9.4. Product portfolio
6.9.5. Business performance
6.9.6. Key strategic moves and developments
6.10. WEST Pharmaceutical Services INC.
6.10.1. Company overview
6.10.2. Company snapshot
6.10.3. Operating business segments
6.10.4. Product portfolio
6.10.5. Business performance
6.10.6. Key strategic moves and developments
1.1. Report description
1.1.1. Key benefits for stakeholders
1.1.2. Key market segments
1.1.3. List of key players profiled in the report
1.2. Research methodology
1.2.1. Secondary research
1.2.2. Primary research
1.2.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Top player positioning, 2020
3.4. Porter’s five forces analysis
3.5. Impact analysis of COVID-19 on the pharmaceutical packaging market
3.6. Market dynamics
3.6.1. Drivers
3.6.1.1. Advanced manufacturing processes to develop sustainable and eco-friendly packaging solutions
3.6.1.2. Increase in product innovations and merger & acquisition to support new demands
3.6.1.3. Emerging generic drug market and rapidly growing drug delivery market
3.6.1.4. Increase in R&D and use of innovative packaging
3.6.2. Restraints
3.6.2.1. Price volatility of raw materials
3.6.2.2. Stringent government regulations and standards
3.6.3. Opportunities
3.6.3.1. Advancement in the biotechnology sector results in the introduction of new parenteral therapies and demand for innovative packaging products
3.6.3.2. Growth in use of the smart packaging for patient engagement and identification
3.6.3.3. Increase in a patient-oriented medicines including biologics
3.6.4. Impact analysis
CHAPTER 4: PHARMACEUTICAL PACKAGING MARKET, BY PRODUCT TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Specialty Bags
4.2.1. Key growth factors and opportunities
4.2.2. Product Type, By Specialty Bags
4.2.2.1. Market size and forecast
4.2.2.2. Urinary Collection Bags
4.2.2.2.1. Market size and forecast
4.2.2.3. Bile Collection Bags
4.2.2.3.1. Market size and forecast
4.2.2.4. Blood Bags
4.2.2.4.1. Market size and forecast
4.2.2.5. Sterile Packaging Bags
4.2.2.5.1. Market size and forecast
4.2.2.6. Enteral Feeding
4.2.2.6.1. Market size and forecast
4.3. Parenteral container
4.3.1. Key market trends and opportunities
4.3.2. Product Type, By Parenteral Container
4.3.2.1. Market size and forecast
4.3.2.2. Bags
4.3.2.2.1. Market size and forecast
4.3.2.3. Bottles
4.3.2.3.1. Market size and forecast
4.3.2.4. Ampoules
4.3.2.4.1. Market size and forecast
4.3.2.5. Vials
4.3.2.5.1. Market size and forecast
4.3.2.6. Cartridges
4.3.2.6.1. Market size and forecast
4.3.2.7. Others
4.3.2.7.1. Market size and forecast
4.4. Others
4.4.1. Key market trends and opportunities
CHAPTER 5: PHARMACEUTICAL PACKAGING MARKET, BY MATERIAL
5.1. Overview
5.1.1. Market size and forecast
5.2. Glass
5.2.1. Key growth factors and opportunities
5.2.2. Market size and forecast
5.3. Aluminum foils
5.3.1. Key growth factors and opportunities
5.3.2. Market size and forecast
5.4. Plastics and polymers
5.4.1. Key growth factors and opportunities
5.4.2. Market size and forecast
5.5. Paper & paperboards
5.5.1. Key growth factors and opportunities
5.5.2. Market size and forecast
5.6. Others
5.6.1. Key growth factors and opportunities
5.6.2. Market size and forecast
CHAPTER 6: COMPANY PROFILES
6.1. Amcor Plc.
6.1.1. Company overview
6.1.2. Company snapshot
6.1.3. Operating business segments
6.1.4. Product portfolio
6.1.5. Business performance
6.1.6. Key strategic moves and developments
6.2. Aptar Group Inc.
6.2.1. Company overview
6.2.2. Company snapshot
6.2.3. Operating business segments
6.2.4. Product Portfolio
6.2.5. Business performance
6.2.6. Key strategic moves and developments
6.3. ESSEL PROPACK LIMITED.
6.3.1. Company overview
6.3.2. Company snapshot
6.3.3. Operating business segments
6.3.4. Product Portfolio
6.3.5. Business performance
6.3.6. Key strategic moves and developments
6.4. Huhtamaki plc.
6.4.1. Company overview
6.4.2. Company snapshot
6.4.3. Operating business segments
6.4.4. Product Portfolio
6.4.5. Business performance
6.4.6. Key strategic moves and developments
6.5. Nipro Corporation
6.5.1. Company overview
6.5.2. Company snapshot
6.5.3. Operating business segments
6.5.4. Product portfolio
6.5.5. Business performance
6.6. Parekhplast plc.
6.6.1. Company overview
6.6.2. Company snapshot
6.6.3. Operating business segments
6.6.4. Product portfolio
6.7. SCHOTT AG
6.7.1. Company overview
6.7.2. Company snapshot
6.7.3. Operating business segments
6.7.4. Product portfolio
6.7.5. Business performance
6.8. SGD PHARMA INDIA LIMITED.
6.8.1. Company overview
6.8.2. Company snapshot
6.8.3. Operating business segments
6.8.4. Product portfolio
6.8.5. Business performance
6.9. UFLEX LIMITED
6.9.1. Company overview
6.9.2. Company snapshot
6.9.3. Operating business segments
6.9.4. Product portfolio
6.9.5. Business performance
6.9.6. Key strategic moves and developments
6.10. WEST Pharmaceutical Services INC.
6.10.1. Company overview
6.10.2. Company snapshot
6.10.3. Operating business segments
6.10.4. Product portfolio
6.10.5. Business performance
6.10.6. Key strategic moves and developments
LIST OF TABLES
TABLE 01. INDIA PHARMACEUTICAL PACKAGING MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 02. INDIA PHARMACEUTICAL PACKAGING MARKET, BY SPECIALITY BAGS , 2020-2030 ($MILLION)
TABLE 03. INDIA PHARMACEUTICAL PACKAGING MARKET, BY PARENTERAL CONTAINER, 2020-2030 ($MILLION)
TABLE 04. INDIA PHARMACEUTICAL PACKAGING MARKET, BY MATERIAL, 2020-2030 ($MILLION)
TABLE 05. AMCOR: COMPANY SNAPSHOT
TABLE 06. AMCOR: OPERATING SEGMENTS
TABLE 07. AMCOR: PRODUCT PORTFOLIO
TABLE 08. APTAR: COMPANY SNAPSHOT
TABLE 09. APTAR: OPERATING SEGMENTS
TABLE 10. APTAR: PRODUCT PORTFOLIO
TABLE 11. EPL: COMPANY SNAPSHOT
TABLE 12. EPL: BUSINESS SEGMENT
TABLE 13. HUHTAMAKI: COMPANY SNAPSHOT
TABLE 14. HUHTAMAKI: BUSINESS SEGMENT
TABLE 15. NIPRO: COMPANY SNAPSHOT
TABLE 16. NIPRO: OPERATING SEGMENTS
TABLE 17. NIPRO: PRODUCT PORTFOLIO
TABLE 18. PAREKHPLAST: COMPANY SNAPSHOT
TABLE 19. PAREKHPLAST: OPERATING SEGMENTS
TABLE 20. PAREKHPLAST: PRODUCT PORTFOLIO
TABLE 21. SCHOTT: COMPANY SNAPSHOT
TABLE 22. SCHOTT: OPERATING SEGMENTS
TABLE 23. SCHOTT: PRODUCT PORTFOLIO
TABLE 24. SGD: COMPANY SNAPSHOT
TABLE 25. SGD: OPERATING SEGMENTS
TABLE 26. SGD: PRODUCT PORTFOLIO
TABLE 27. ULFEX: COMPANY SNAPSHOT
TABLE 28. ULFEX: OPERATING SEGMENTS
TABLE 29. ULFEX: PRODUCT PORTFOLIO
TABLE 30. WEST: COMPANY SNAPSHOT
TABLE 31. WEST: OPERATING SEGMENTS
TABLE 32. WEST: PRODUCT PORTFOLIO
TABLE 01. INDIA PHARMACEUTICAL PACKAGING MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 02. INDIA PHARMACEUTICAL PACKAGING MARKET, BY SPECIALITY BAGS , 2020-2030 ($MILLION)
TABLE 03. INDIA PHARMACEUTICAL PACKAGING MARKET, BY PARENTERAL CONTAINER, 2020-2030 ($MILLION)
TABLE 04. INDIA PHARMACEUTICAL PACKAGING MARKET, BY MATERIAL, 2020-2030 ($MILLION)
TABLE 05. AMCOR: COMPANY SNAPSHOT
TABLE 06. AMCOR: OPERATING SEGMENTS
TABLE 07. AMCOR: PRODUCT PORTFOLIO
TABLE 08. APTAR: COMPANY SNAPSHOT
TABLE 09. APTAR: OPERATING SEGMENTS
TABLE 10. APTAR: PRODUCT PORTFOLIO
TABLE 11. EPL: COMPANY SNAPSHOT
TABLE 12. EPL: BUSINESS SEGMENT
TABLE 13. HUHTAMAKI: COMPANY SNAPSHOT
TABLE 14. HUHTAMAKI: BUSINESS SEGMENT
TABLE 15. NIPRO: COMPANY SNAPSHOT
TABLE 16. NIPRO: OPERATING SEGMENTS
TABLE 17. NIPRO: PRODUCT PORTFOLIO
TABLE 18. PAREKHPLAST: COMPANY SNAPSHOT
TABLE 19. PAREKHPLAST: OPERATING SEGMENTS
TABLE 20. PAREKHPLAST: PRODUCT PORTFOLIO
TABLE 21. SCHOTT: COMPANY SNAPSHOT
TABLE 22. SCHOTT: OPERATING SEGMENTS
TABLE 23. SCHOTT: PRODUCT PORTFOLIO
TABLE 24. SGD: COMPANY SNAPSHOT
TABLE 25. SGD: OPERATING SEGMENTS
TABLE 26. SGD: PRODUCT PORTFOLIO
TABLE 27. ULFEX: COMPANY SNAPSHOT
TABLE 28. ULFEX: OPERATING SEGMENTS
TABLE 29. ULFEX: PRODUCT PORTFOLIO
TABLE 30. WEST: COMPANY SNAPSHOT
TABLE 31. WEST: OPERATING SEGMENTS
TABLE 32. WEST: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01. INDIA PHARMACEUTICAL PACKAGING MARKETSEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 2018–2021*
FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018–2021* (%)
FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 2018–2021* (%)
FIGURE 06. TOP PLAYER POSITIONING, 2020
FIGURE 07. HIGH BARGAINING POWER OF BUYERS
FIGURE 08. HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 09. HIGH THREAT OF NEW ENTRANTS
FIGURE 10. MODERATE THREAT OF SUBSTITUTION
FIGURE 11. MODERATE COMPETITIVE RIVALRY
FIGURE 12. IMPACT ANALYSIS:
FIGURE 13. INDIA PHARMACEUTICAL PACKAGING MARKET,BY URINARY COLLECTION BAGS 2020–2030 ($MILLION)
FIGURE 14. INDIA PHARMACEUTICAL PACKAGING MARKET, BY BILE COLLECTION BAGS 2020–2030 ($MILLION)
FIGURE 15. INDIA PHARMACEUTICAL PACKAGING MARKET, BY BLOOD BAGS 2020–2030 ($MILLION)
FIGURE 16. INDIA PHARMACEUTICAL PACKAGING MARKET, BY STERILE PACKAGING BAGS 2020–2030, ($MILLION)
FIGURE 17. INDIA PHARMACEUTICAL PACKAGING MARKET, BY ENTERAL FEEDING, 2020–2030 ($MILLION)
FIGURE 18. INDIA PHARMACEUTICAL PACKAGING MARKET, BY BAGS, 2020–2030 ($MILLION)
FIGURE 19. INDIA PHARMACEUTICAL PACKAGING MARKET , BY BOTTLES, 2020–2030 ($MILLION)
FIGURE 20. INDIA PHARMACEUTICAL PACKAGING MARKET, BY AMPOULES 2020–2030 ($MILLION)
FIGURE 21. INDIA PHARMACEUTICAL PACKAGING MARKET, BY VIALS 2020–2030 ($MILLION)
FIGURE 22. INDIA PHARMACEUTICAL PACKAGING MARKET, BY CARTRIDGES 2020–2030 ($MILLION)
FIGURE 23. INDIA PHARMACEUTICAL PACKAGING MARKET, BY OTHERS 2020–2030 ($MILLION)
FIGURE 24. INDIA PHARMACEUTICAL PACKAGING MARKET, BY GLASS, 2020–2030 ($MILLION)
FIGURE 25. INDIA PHARMACEUTICAL PACKAGING MARKET, BY ALUMINUM FOILS 2020–2030 ($MILLION)
FIGURE 26. INDIA PHARMACEUTICAL PACKAGING MARKET, BY PLASTICS AND POLYMERS 2020–2030 ($MILLION)
FIGURE 27. INDIA PHARMACEUTICAL PACKAGING MARKET, BY PAPER AND PAPERBOARDS, 2020–2030 ($MILLION)
FIGURE 28. INDIA PHARMACEUTICAL PACKAGING MARKET, BY OTHERS, 2020–2030 ($MILLION)
FIGURE 29. AMCOR: NET SALES, 2018–2020 ($MILLION)
FIGURE 30. AMCOR: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 31. AMCOR: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 32. NET SALES, 2018–2020 ($MILLION)
FIGURE 33. APTAR: NET SALES BY DIVISION, 2020 (%)
FIGURE 34. APTAR: NET SALES BY REGION, 2020 (%)
FIGURE 35. NET SALES, 2018–2020 ($MILLION)
FIGURE 36. NET SALES, 2018–2020 ($MILLION)
FIGURE 37. HUHTAMAKI: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 38. NET SALES, 2018–2020 ($MILLION)
FIGURE 39. NIPRO REVENUE SHARE BY BUSINESS UNIT, 2020 (%)
FIGURE 40. NIPRO: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 41. NET SALES, 2017–2019 ($MILLION)
FIGURE 42. SCHOTT: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 43. NET SALES, 2018–2020 ($MILLION)
FIGURE 44. SGD: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 45. ULFEX: NET SALES, 2018–2020 ($MILLION)
FIGURE 46. ULFEX: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 47. WEST NET SALES, 2019–2020 ($MILLION)
FIGURE 48. WEST: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 49. WEST: REVENUE SHARE BY GEOGRAPHY, 2020 (%)
FIGURE 01. INDIA PHARMACEUTICAL PACKAGING MARKETSEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 2018–2021*
FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018–2021* (%)
FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 2018–2021* (%)
FIGURE 06. TOP PLAYER POSITIONING, 2020
FIGURE 07. HIGH BARGAINING POWER OF BUYERS
FIGURE 08. HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 09. HIGH THREAT OF NEW ENTRANTS
FIGURE 10. MODERATE THREAT OF SUBSTITUTION
FIGURE 11. MODERATE COMPETITIVE RIVALRY
FIGURE 12. IMPACT ANALYSIS:
FIGURE 13. INDIA PHARMACEUTICAL PACKAGING MARKET,BY URINARY COLLECTION BAGS 2020–2030 ($MILLION)
FIGURE 14. INDIA PHARMACEUTICAL PACKAGING MARKET, BY BILE COLLECTION BAGS 2020–2030 ($MILLION)
FIGURE 15. INDIA PHARMACEUTICAL PACKAGING MARKET, BY BLOOD BAGS 2020–2030 ($MILLION)
FIGURE 16. INDIA PHARMACEUTICAL PACKAGING MARKET, BY STERILE PACKAGING BAGS 2020–2030, ($MILLION)
FIGURE 17. INDIA PHARMACEUTICAL PACKAGING MARKET, BY ENTERAL FEEDING, 2020–2030 ($MILLION)
FIGURE 18. INDIA PHARMACEUTICAL PACKAGING MARKET, BY BAGS, 2020–2030 ($MILLION)
FIGURE 19. INDIA PHARMACEUTICAL PACKAGING MARKET , BY BOTTLES, 2020–2030 ($MILLION)
FIGURE 20. INDIA PHARMACEUTICAL PACKAGING MARKET, BY AMPOULES 2020–2030 ($MILLION)
FIGURE 21. INDIA PHARMACEUTICAL PACKAGING MARKET, BY VIALS 2020–2030 ($MILLION)
FIGURE 22. INDIA PHARMACEUTICAL PACKAGING MARKET, BY CARTRIDGES 2020–2030 ($MILLION)
FIGURE 23. INDIA PHARMACEUTICAL PACKAGING MARKET, BY OTHERS 2020–2030 ($MILLION)
FIGURE 24. INDIA PHARMACEUTICAL PACKAGING MARKET, BY GLASS, 2020–2030 ($MILLION)
FIGURE 25. INDIA PHARMACEUTICAL PACKAGING MARKET, BY ALUMINUM FOILS 2020–2030 ($MILLION)
FIGURE 26. INDIA PHARMACEUTICAL PACKAGING MARKET, BY PLASTICS AND POLYMERS 2020–2030 ($MILLION)
FIGURE 27. INDIA PHARMACEUTICAL PACKAGING MARKET, BY PAPER AND PAPERBOARDS, 2020–2030 ($MILLION)
FIGURE 28. INDIA PHARMACEUTICAL PACKAGING MARKET, BY OTHERS, 2020–2030 ($MILLION)
FIGURE 29. AMCOR: NET SALES, 2018–2020 ($MILLION)
FIGURE 30. AMCOR: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 31. AMCOR: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 32. NET SALES, 2018–2020 ($MILLION)
FIGURE 33. APTAR: NET SALES BY DIVISION, 2020 (%)
FIGURE 34. APTAR: NET SALES BY REGION, 2020 (%)
FIGURE 35. NET SALES, 2018–2020 ($MILLION)
FIGURE 36. NET SALES, 2018–2020 ($MILLION)
FIGURE 37. HUHTAMAKI: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 38. NET SALES, 2018–2020 ($MILLION)
FIGURE 39. NIPRO REVENUE SHARE BY BUSINESS UNIT, 2020 (%)
FIGURE 40. NIPRO: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 41. NET SALES, 2017–2019 ($MILLION)
FIGURE 42. SCHOTT: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 43. NET SALES, 2018–2020 ($MILLION)
FIGURE 44. SGD: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 45. ULFEX: NET SALES, 2018–2020 ($MILLION)
FIGURE 46. ULFEX: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 47. WEST NET SALES, 2019–2020 ($MILLION)
FIGURE 48. WEST: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 49. WEST: REVENUE SHARE BY GEOGRAPHY, 2020 (%)
